Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply

被引：0
|
作者：
Gordon, Stuart C. [1 ]
Yee, Leland J. [2 ]
Martins, Eduardo Bruno [2 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Gilead Sci, Foster City, CA USA
来源：
HEPATOLOGY | 2014年 / 59卷 / 06期
关键词：
D O I：
10.1002/hep.26902
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2427 / 2427
页数：1
相关论文
共 50 条
  • [21] Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
    Price, Jennifer C.
    Murphy, Rosemary C.
    Shvachko, Valentina A.
    Pauly, Mary Pat
    Manos, M. Michele
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (12) : 3043 - 3052
  • [22] Expert Opinion on Boceprevir- and Telaprevir-Based Triple Therapies of Chronic Hepatitis C
    Sarrazin, C.
    Berg, T.
    Cornberg, M.
    Dollinger, M.
    Ferenci, P.
    Hinrichsen, H.
    Klinker, H.
    Kraus, M.
    Manns, M.
    Mauss, S.
    Peck-Radosavljevic, M.
    Schmidt, H.
    Spengler, U.
    Wedemeyer, H.
    Wirth, S.
    Zeuzem, S.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (01): : 57 - 72
  • [23] Evaluation of requests telaprevir/boceprevir for the treatment of chronic hepatitis C
    Carrascosa Piquer, Olga
    De La Vega, Ivan
    Aparicio, Celia
    Mejia, Luisa
    Antonino, Gonzalo
    Garcia del Busto, Natalia
    Quintana, Belen
    Sanchez, Agustin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 246 - 246
  • [24] Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
    Fukuda, Kazuto
    Imai, Yasuharu
    Hiramatsu, Naoki
    Irishio, Keiko
    Igura, Takumi
    Sawai, Yoshiyuki
    Kogita, Sachiyo
    Makino, Yuki
    Mizumoto, Rui
    Matsumoto, Yasushi
    Nakahara, Masanori
    Zushi, Sinichiro
    Kajiwara, Nobuyuki
    Oze, Tsugiko
    Kawata, Sumio
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY RESEARCH, 2014, 44 (12) : 1165 - 1171
  • [25] Triple therapy with boceprevir or telaprevir for treatment naive HCV patients
    Esteban, Rafael
    Buti, Maria
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (04) : 445 - 453
  • [26] Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C
    Kohjima, Motoyuki
    Kurokawa, Miho
    Enjoji, Munechika
    Yoshimoto, Tsuyoshi
    Nakamura, Tsukasa
    Ohashi, Tomoko
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Murata, Yusuke
    Matsunaga, Kazuhisa
    Kato, Masaki
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1781 - 1787
  • [27] Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation''
    Coilly, Audrey
    Sebagh, Mylene
    Duclos-Vallee, Jean-Charles
    JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 896 - 897
  • [28] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
  • [29] Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
    Neukam, Karin
    Munteanu, Daniela I.
    Rivero-Juarez, Antonio
    Lutz, Thomas
    Fehr, Jan
    Mandorfer, Mattias
    Bhagani, Sanjay
    Lopez-Cortes, Luis F.
    Haberl, Annette
    Stoeckle, Marcel
    Marquez, Manuel
    Scholten, Stefan
    de los Santos-Gil, Ignacio
    Mauss, Stefan
    Rivero, Antonio
    Collado, Antonio
    Delgado, Marcial
    Rockstroh, Juergen K.
    Pineda, Juan A.
    PLOS ONE, 2015, 10 (04):
  • [30] BOCEPREVIR AND TELAPREVIR BASED TRIPLE THERAPY FOR CHRONIC HEPATITIS C: ON-TREATMENT EFFICACY AND IMPACT ON KIDNEY FUNCTION AND MELD SCORE
    Virlogeux, V.
    Goncalves, F.
    Pradat, P.
    Maynard, M.
    Hartig-Lavie, K.
    Amiri, M.
    Scholtes, C.
    Andre, P.
    Bailly, F.
    Zoulim, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S377 - S378
12345